1. Home
  2. SNY vs SBUX Comparison

SNY vs SBUX Comparison

Compare SNY & SBUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • SBUX
  • Stock Information
  • Founded
  • SNY 1994
  • SBUX 1971
  • Country
  • SNY France
  • SBUX United States
  • Employees
  • SNY N/A
  • SBUX N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • SBUX Restaurants
  • Sector
  • SNY Health Care
  • SBUX Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • SBUX Nasdaq
  • Market Cap
  • SNY 127.5B
  • SBUX 113.2B
  • IPO Year
  • SNY N/A
  • SBUX 1992
  • Fundamental
  • Price
  • SNY $47.60
  • SBUX $99.95
  • Analyst Decision
  • SNY Buy
  • SBUX Buy
  • Analyst Count
  • SNY 2
  • SBUX 27
  • Target Price
  • SNY $57.50
  • SBUX $102.88
  • AVG Volume (30 Days)
  • SNY 2.3M
  • SBUX 8.0M
  • Earning Date
  • SNY 10-25-2024
  • SBUX 10-30-2024
  • Dividend Yield
  • SNY 4.27%
  • SBUX 2.49%
  • EPS Growth
  • SNY N/A
  • SBUX N/A
  • EPS
  • SNY 4.00
  • SBUX 3.31
  • Revenue
  • SNY $54,031,898,261.00
  • SBUX $36,176,200,000.00
  • Revenue This Year
  • SNY $3.18
  • SBUX $5.20
  • Revenue Next Year
  • SNY $6.67
  • SBUX $6.91
  • P/E Ratio
  • SNY $23.82
  • SBUX $29.71
  • Revenue Growth
  • SNY 6.01
  • SBUX 0.56
  • 52 Week Low
  • SNY $45.22
  • SBUX $71.55
  • 52 Week High
  • SNY $58.97
  • SBUX $104.68
  • Technical
  • Relative Strength Index (RSI)
  • SNY 24.92
  • SBUX 56.67
  • Support Level
  • SNY $47.46
  • SBUX $97.11
  • Resistance Level
  • SNY $48.67
  • SBUX $100.61
  • Average True Range (ATR)
  • SNY 0.68
  • SBUX 2.08
  • MACD
  • SNY -0.26
  • SBUX 0.01
  • Stochastic Oscillator
  • SNY 4.43
  • SBUX 72.78

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About SBUX Starbucks Corporation

Starbucks is one of the most widely recognized restaurant brands in the world, operating more than 40,000 stores across more than 80 countries as of the end of fiscal 2024. The firm operates in three segments: North America, international markets, and channel development (grocery and ready-to-drink beverage). The coffee chain generates revenue from company-operated stores, royalties, sales of equipment and products to license partners, ready-to-drink beverages, packaged coffee sales, and single-serve products.

Share on Social Networks: